News & Events

Publications

Heinz Zwierzina et al., The preclinical and clinical activity of aviscumine: A potential anticancer drug, European Journal of Cancer 47: 1450-1457 (2011). Heinz Zwierzina et al., The preclinical and clinical activity of aviscumine: A potential anticancer drug, European Journal of Cancer 47: 1450-1457 (2011). (261.0 kB)

L. Bergmann et al., Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001), European Journal of Cancer 44: 1657-1662 (2008).

P. Schöffski et al., Weekly 24h infusion of aviscumine (rViscumin): A phase I study in patients with solid tumours, European Journal of Cancer 41: 1431-1438 (2005).

P. Schöffski et al., Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: A study of the European Organization for Research and Treatment of Cancer New Drug Development Group, Annals of Oncology 15: 1816-1824 (2004).